A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease
Year of publication: |
2007
|
---|---|
Authors: | Rutten-van Molken, Maureen P.M.H. ; van Nooten, Floortje E. ; Lindemann, Marion ; Caeser, Manfred ; Calverley, Peter M.A. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 25.2007, 8, p. 695-711
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Chronic-obstructive-pulmonary-disease | Cost-effectiveness | Randomised-controlled-trials | Roflumilast |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Tapering Off Benzodiazepines in Long-Term Users: An Economic Evaluation
Oude Voshaar, Richard C., (2006)
-
Walters, Daniel J., (1999)
-
Sample Size Determination for Cost-Effectiveness Trials
Willan, Andrew R., (2011)
- More ...
-
Direct Costs of Treatment of COPD in a German Sickness Fund
Freytag, Antje, (2007)
-
Korthals-de Bos, Ingeborg B.C., (2004)
-
Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma
Rutten-van Molken, Maureen P.M.H., (1998)
- More ...